Helixmith Co., Ltd (KOSDAQ:084990)
South Korea · Delayed Price · Currency is KRW 4,180.00
+70.00 (1.70%)
Aug 8, 2025, 3:30 PM KST
SolarWinds Market Cap
Helixmith has a market cap or net worth of 192.48 billion as of August 8, 2025. Its market cap has increased by 19.77% in one year.
Market Cap
192.48B
Enterprise Value
110.85B
Revenue
5.09B
Ranking
n/a
PE Ratio
n/a
Stock Price
$4,180.00
Market Cap Chart
Since December 29, 2005, Helixmith's market cap has decreased from 238.64B to 192.48B, a decrease of -19.35%. That is a compound annual growth rate of -1.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 189.25B | 52.22% |
| Dec 30, 2024 | 124.33B | -51.50% |
| Dec 28, 2023 | 256.37B | -35.45% |
| Dec 29, 2022 | 397.14B | -53.54% |
| Dec 30, 2021 | 854.88B | -3.11% |
| Dec 30, 2020 | 882.29B | -55.53% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.38T |
| Celltrion | 38.03T |
| ALTEOGEN | 23.49T |
| Yuhan | 8,568.09B |
| SK Biopharmaceuticals | 7,948.79B |
| Peptron | 7,292.07B |
| PharmaResearch | 6,316.91B |
| HLB Co., Ltd. | 5,850.60B |